跳至主要内容
临床试验/NL-OMON20542
NL-OMON20542招募中3 期

Safety of topical 5-FU cream in patients carrying a clinically relevant DPYD variant – The DPYDIX study

Stichting de Merel0 个研究点目标入组 550 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Age = 18 years - Able to understand the written information and able to give informed consent - Planned treatment with topical 5-FU cream (Efudix) for any indication - Possibility to take photos of the treatment area at the designated times and send them digitally

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study: - Prior treatment with fluoropyrimidines - Known allergy to (components of) 5-FU cream - Pregnancy, breast-feeding, active child wish - Concomitant use of systemic retinoids - Patients with known substance abuse, psychotic disorders, and/or other diseases expected to interfere with study or the patient’s safety in the opinion of the treating physician

研究者

发起方
Stichting de Merel

相似试验